Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	2.27	75.54	73.86
Graham Fair Price	2.85	18.19	17.68
PEG	15456.79	7.20	0.05
Price/Book	3.49	9.50	9.18
Price/Cash Flow	222.64	152.07	47.13
Prices/Earnings	-1.29	41.36	41.90
Price/Sales	12.71	13.86	12.29
Price/FCF	222.64	152.07	47.13
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-1.44	0.72	0.73
Operating Margin	-3.35	0.13	0.14
ROA	8.14	0.01	0.01
ROE	0.05	0.06	4.84
ROIC	0.03	0.02	-10.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.04	< 0.005	419.65
Dividends QOQ	< 0.005	< 0.005	24.59
EBIT QOQ	5.07	-0.11	-97.88
EPS QOQ	9.06	0.06	-99.37
FCF QOQ	2.58	-0.68	-73.77
Revenue QOQ	0.21	-0.08	-64.01
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	203.01	187.56	-7.61
Days Sales Outstanding (DSO)	36.95	42.35	14.60
Inventory Turnover	0.44	0.48	8.24
Debt/Capitalization	0.60	0.63	5.54
Quick Ratio	0.87	1.03	18.48
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	15.92	16.00	0.45
Cash	10.98	10.31	-6.15
Capex	-0.65	-0.49	24.65
Free Cash Flow	3.10	1.00	-67.78
Revenue	11.90	10.97	-7.77
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.36	1.58	16.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.88	7.64	-3.06
Naive Interpretation	Member

06 - Financial Health · Weak

Rating